FDA.reportPublic FDA data

MODEYSO 125 MG Oral Capsule

RxCUI
2721205
RxNorm name
MODEYSO 125 MG Oral Capsule
Display name
MODEYSO 125 MG Oral Capsule
Full name
MODEYSO 125 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MODEYSODORDAVIPRONEJazz Pharmaceuticals, Inc.ad45b43e-fdef-47ad-9c34-055b41bdc5762026-01-09Warnings, Adverse reactionsExact identifier
rxcui: 2721205

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ad45b43e-fdef-47ad-9c34-055b41bdc576MODEYSO 125 MG Oral Capsule [PSN] · dordaviprone 125 MG Oral Capsule [Modeyso] [SBD] · Modeyso 125 MG (equivalent to dordaviprone hydrochloride 148.8 MG) Oral Capsule [SY]32These highlights do not include all the information needed to use MODEYSO safely and effectively. See full prescribing information for MODEYSO. MODEYSO™ (dordaviprone) capsules, for oral use Initial U.S. Approval: 202520260109